company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4087000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4087000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,71000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-108000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4093000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4093000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,34884000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,65000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-59000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34890000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34890000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2013.0,Q4,2012-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30786000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4149000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4149000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,73000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,78000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-524000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4522000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4522000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-60000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-60000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4565000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5491000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5491000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,82000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,133000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,695000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4581000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4581000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-122000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,70000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-52000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-52000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,3000000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,145000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-17000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3128000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3128000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q2,2013-10-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1505000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5239000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5239000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,102000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,166000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-686000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5657000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5657000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-304000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-304000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-304000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,12959000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,104000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13063000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13063000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q3,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7102000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21712000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21712000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,361000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,691000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1429000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19231000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19231000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-556000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,70000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-486000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-486000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,15959000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71907000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87866000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87866000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2014.0,Q4,2014-01-01,2014-12-31,2017-03-16 16:07:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68149000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7858000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7858000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,109000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,587000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-469000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7629000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7629000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20406000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20470000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20470000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:06:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28092000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7818000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7818000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,119000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,789000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,802000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5998000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5998000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-221000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61151000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4536000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56836000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56836000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,283000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,276000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,276000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q2,2014-10-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-62558000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8900000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8900000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,156000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,877000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1383000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6392000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6392000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7289000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10586000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3242000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3242000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,262000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,262000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,262000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q3,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2888000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8068000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8068000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,84000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,178000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1012000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3120000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9914000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9914000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20253000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27642000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7288000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7288000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,300000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,300000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,300000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2015.0,Q4,2014-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2326000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9582000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9582000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,85000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,175000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1027000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,689000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7606000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7606000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-165000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12486000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22075000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9424000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9424000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4243000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4243000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4243000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:28:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6061000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10358000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10358000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,168000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1087000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1394000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7642000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7642000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11574000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14495000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2875000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2875000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-73000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-73000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-73000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q2,2015-10-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4840000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8544000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8544000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,70000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1073000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,255000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7004000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7004000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11751000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19970000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8193000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8193000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3085000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3085000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3085000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q3,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4274000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9520000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9520000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,75000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1063000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-496000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8773000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8773000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-164000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8807000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12184000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3213000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3213000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4561000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4561000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4561000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2016.0,Q4,2015-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-999000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5587000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5587000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,80000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,79000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1149000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,39530000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,35251000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35251000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94015000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17100000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76965000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76965000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,120505000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,74000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,120579000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,120579000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:21:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78865000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5194000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5194000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,84000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,152000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1360000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4766000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1168000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1168000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-177000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52253000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19809000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-32621000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-32621000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,452000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-74000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,378000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,378000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31075000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6071000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6071000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,125000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1465000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6914000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11305000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11305000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-455000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28089000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21040000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7504000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7504000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,223000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,223000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,223000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18586000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10974000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10974000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,90000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1571000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2161000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11363000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11363000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-547000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20293000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39499000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18659000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18659000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,75386000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-73618000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1768000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1768000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9064000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13206000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13206000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,124000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1881000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3787000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14952000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14952000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16832000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38026000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21168000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21168000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,150000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,150000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,150000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:01:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6366000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3075000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3075000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,124000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-31000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1920000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18378000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19440000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19440000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24517000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44644000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20091000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20091000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,528000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-150000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,378000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,378000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1029000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18849000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18849000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,127000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-129000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1816000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,473000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16562000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16562000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-122000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5943000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22200000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16135000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16135000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5692000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5692000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5692000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5265000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19499000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19499000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,130000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-148000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1820000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3809000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13888000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13888000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28815000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24250000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4595000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4595000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8406000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8406000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8406000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10077000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23687000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23687000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-210000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2012000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1136000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20624000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20624000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14104000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23100000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8996000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8996000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1146000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1154000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1154000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10474000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24152000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24152000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-234000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2132000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2079000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20050000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20050000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36926000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37200000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,274000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,274000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,54044000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1948000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55984000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55984000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36208000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20293000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20293000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,116000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-286000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1876000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1089000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19676000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19676000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76950000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41750000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35208000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35208000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-284000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,37000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-247000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-247000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-55131000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21728000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21728000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,113000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-167000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1812000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1575000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18395000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18395000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25247000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40400000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15154000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15154000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42017000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42017000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42017000.0
Calithera Biosciences Inc,CALA,54930042TDFRLM4C8X19,0001496671,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38776000.0
